AG
STJ

Advisor Group’s St Jude Medical STJ Stock Holding History

Advisor Group’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3,029
Closed -$243K – 4956
2016
Q4 		$243K Sell
3,029
-4,725
-61% -$375K 0.01% 1431
2016
Q3 		$618K Sell
7,754
-861
-10% -$69.5K 0.01% 861
2016
Q2 		$669K Buy
+8,615
New +$614K 0.02% 770

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Advisor Group's STJ Position: Q1 2017 in Review

Advisor Group sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 3,029 shares — an estimated $243K sold.

Advisor Group first reported a position in STJ in Q2 2016 and held it in 3 quarters. The position peaked at $669K in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Advisor Group reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Advisor Group sold 3,029 St Jude Medical shares in Q1 2017, an estimated $243K.
  • Advisor Group first reported a position in St Jude Medical in Q2 2016 and held it in 3 quarters.
  • Advisor Group's St Jude Medical position peaked at $669K in Q2 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Advisor Group's 13F filing for Q1 2017, filed 15 May 2017.